如何预防中心静脉导管相关血流感染?

2019-05-14 不详 网络

一些慢性疾病患者因治疗所需,将长期放置中心静脉导管。如果发生中心静脉导管(CVCs)相关的血流感染(BSI)将导致患者死亡率、患病率增加,并增加治疗成本,因此,预防中心静脉导管相关血流感染意义重大,

临床问题

如何预防中心静脉导管相关血流感染

临床问题

一些慢性疾病患者因治疗所需,将长期放置中心静脉导管。如果发生中心静脉导管(CVCs)相关的血流感染(BSI)将导致患者死亡率、患病率增加,并增加治疗成本,因此,预防中心静脉导管相关血流感染意义重大,现将有关证据汇总如下。

证据描述

一项meta分析表明,使用葡萄糖酸氯己定(CHG)溶液进行局部消毒比使用聚维酮碘(PI)溶液减少约49%的住院患者导管相关性血流感染(CRBSI)的风险1。(Level I)

没有证据显示口服或肠外使用抗生素或抗真菌药物可减少成人CRBSI的发病率1。(Level I)

一篇随机对照试验的meta分析评价了肝素对导管通畅时间的影响和对预防静脉和动脉导管相关并发症的效果,认为10U/ml肝素间歇冲洗并不比用生理盐水冲洗更有利1。(Level I)

三项随机对照试验结果显示,不低于每72小时更换一次CVC 敷料的频率是安全的且符合成本效益。当输注的液体可能促进微生物生长时(如:脂肪乳剂、血制品),需要加快敷料更换频率,因为这些物质是CRBSI的独立危险因素1。(Level I)

一篇系统评价发现锁骨下中心静脉通路优于股静脉通路,因为无论长期还是短期置管,其发生感染、血栓等并发症的风险较低2,3。(Level I)

此外,锁骨下动脉和颈内静脉长时间置管,发生导管相关血流感染的风险是相似的3。(Level I)

推荐在CVC插入前用酒精或2%葡萄糖酸氯己定清洁皮肤4。(Level I)

一篇针对如何减少小儿CVC感染的系统评价推荐用2%葡萄糖酸氯己定(洗必泰)做皮肤准备,可以减少CVC定植菌和血液感染。使用洗必泰敷料可以降低导管相关血流感染的发生率5。(Level I)

实践推荐

中心静脉导管护理过程中接触导管系统时必须使用无菌技术。(Grade B)

接触或更换中心静脉导管敷料前,必须用抗菌皂液和清水洗手,或用酒精搓手。若手上有可见污物或被灰尘、有机物污染,在用酒精搓手前必须用肥皂和水清洗。 (Grade A)

手消毒以后,戴用无菌手套更换插管部位的敷料。 (Grade B)

最好用无菌、透明、半渗透性聚氨酯敷料敷盖导管插入点。(Grade A)

如果患者出汗过多,或插入部位有出血或渗血,最好采用透明、半渗透性敷料。纱布敷料应尽早更换为透明辅料。(Grade B)

更换敷料时需要用酒精溶液或葡萄糖酸氯己定清洁导管穿刺点,并保持干燥。 (Grade A)

最好用0.9%无菌氯化钠注射液冲洗和封腔。(Grade B)

正常情况,连续使用CVC时的装置更换频率不必高于每72小时更换一次,除非导管断开或怀疑或证实有导管相关性感染 。(Grade A)

通过CVC输注血液和血制品的装置应为每12小时更换一次,或根据制造商的建议。(Grade B)

用于全肠外营养(TPN)输注的装置一般应为每24小时更换一次。如果溶液只包含葡萄糖和氨基酸,在连续使用时更换频率不高于每72小时一次。(Grade B)

不推荐通过定期更换短期导管以降低感染率 。(Grade B)

CVC插入24小时后需更换敷料,然后每周换一次,除非有特殊需更换的指征(如有渗出)。(Grade B)

若非紧急情况应避免插入股静脉。(Grade A)

常规使用生理盐水冲洗CVC 。(Grade A)

适用性说明

本证据来自于国内外循证资源,在应用该证据时,应考虑具体的临床情境、专业判断和患者意愿,做出最佳决策。


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1052890, encodeId=99b010528901f, content=请问出处在哪?, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76735610860, createdName=ms1000001709809472, createdTime=Sat Sep 18 21:28:53 CST 2021, time=2021-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796991, encodeId=7d971e969912b, content=<a href='/topic/show?id=5a6e221853a' target=_blank style='color:#2F92EE;'>#中心静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22185, encryptionId=5a6e221853a, topicName=中心静脉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8f4110, createdName=guojianrong, createdTime=Mon May 20 21:20:00 CST 2019, time=2019-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1697902, encodeId=a241169e9029c, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Wed Oct 30 19:20:00 CST 2019, time=2019-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1365550, encodeId=54d5136555082, content=<a href='/topic/show?id=e2ff2218823' target=_blank style='color:#2F92EE;'>#中心静脉导管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22188, encryptionId=e2ff2218823, topicName=中心静脉导管)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f32220, createdName=lancelotzzl, createdTime=Thu May 16 01:20:00 CST 2019, time=2019-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1511874, encodeId=d60815118e492, content=<a href='/topic/show?id=d88b891e376' target=_blank style='color:#2F92EE;'>#血流感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89173, encryptionId=d88b891e376, topicName=血流感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83b410387887, createdName=ms6829001416292975, createdTime=Thu May 16 01:20:00 CST 2019, time=2019-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=366210, encodeId=6b683662105f, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Tue May 14 10:48:30 CST 2019, time=2019-05-14, status=1, ipAttribution=)]
    2021-09-18 ms1000001709809472

    请问出处在哪?

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1052890, encodeId=99b010528901f, content=请问出处在哪?, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76735610860, createdName=ms1000001709809472, createdTime=Sat Sep 18 21:28:53 CST 2021, time=2021-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796991, encodeId=7d971e969912b, content=<a href='/topic/show?id=5a6e221853a' target=_blank style='color:#2F92EE;'>#中心静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22185, encryptionId=5a6e221853a, topicName=中心静脉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8f4110, createdName=guojianrong, createdTime=Mon May 20 21:20:00 CST 2019, time=2019-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1697902, encodeId=a241169e9029c, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Wed Oct 30 19:20:00 CST 2019, time=2019-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1365550, encodeId=54d5136555082, content=<a href='/topic/show?id=e2ff2218823' target=_blank style='color:#2F92EE;'>#中心静脉导管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22188, encryptionId=e2ff2218823, topicName=中心静脉导管)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f32220, createdName=lancelotzzl, createdTime=Thu May 16 01:20:00 CST 2019, time=2019-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1511874, encodeId=d60815118e492, content=<a href='/topic/show?id=d88b891e376' target=_blank style='color:#2F92EE;'>#血流感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89173, encryptionId=d88b891e376, topicName=血流感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83b410387887, createdName=ms6829001416292975, createdTime=Thu May 16 01:20:00 CST 2019, time=2019-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=366210, encodeId=6b683662105f, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Tue May 14 10:48:30 CST 2019, time=2019-05-14, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1052890, encodeId=99b010528901f, content=请问出处在哪?, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76735610860, createdName=ms1000001709809472, createdTime=Sat Sep 18 21:28:53 CST 2021, time=2021-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796991, encodeId=7d971e969912b, content=<a href='/topic/show?id=5a6e221853a' target=_blank style='color:#2F92EE;'>#中心静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22185, encryptionId=5a6e221853a, topicName=中心静脉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8f4110, createdName=guojianrong, createdTime=Mon May 20 21:20:00 CST 2019, time=2019-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1697902, encodeId=a241169e9029c, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Wed Oct 30 19:20:00 CST 2019, time=2019-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1365550, encodeId=54d5136555082, content=<a href='/topic/show?id=e2ff2218823' target=_blank style='color:#2F92EE;'>#中心静脉导管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22188, encryptionId=e2ff2218823, topicName=中心静脉导管)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f32220, createdName=lancelotzzl, createdTime=Thu May 16 01:20:00 CST 2019, time=2019-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1511874, encodeId=d60815118e492, content=<a href='/topic/show?id=d88b891e376' target=_blank style='color:#2F92EE;'>#血流感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89173, encryptionId=d88b891e376, topicName=血流感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83b410387887, createdName=ms6829001416292975, createdTime=Thu May 16 01:20:00 CST 2019, time=2019-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=366210, encodeId=6b683662105f, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Tue May 14 10:48:30 CST 2019, time=2019-05-14, status=1, ipAttribution=)]
    2019-10-30 fusion
  4. [GetPortalCommentsPageByObjectIdResponse(id=1052890, encodeId=99b010528901f, content=请问出处在哪?, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76735610860, createdName=ms1000001709809472, createdTime=Sat Sep 18 21:28:53 CST 2021, time=2021-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796991, encodeId=7d971e969912b, content=<a href='/topic/show?id=5a6e221853a' target=_blank style='color:#2F92EE;'>#中心静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22185, encryptionId=5a6e221853a, topicName=中心静脉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8f4110, createdName=guojianrong, createdTime=Mon May 20 21:20:00 CST 2019, time=2019-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1697902, encodeId=a241169e9029c, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Wed Oct 30 19:20:00 CST 2019, time=2019-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1365550, encodeId=54d5136555082, content=<a href='/topic/show?id=e2ff2218823' target=_blank style='color:#2F92EE;'>#中心静脉导管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22188, encryptionId=e2ff2218823, topicName=中心静脉导管)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f32220, createdName=lancelotzzl, createdTime=Thu May 16 01:20:00 CST 2019, time=2019-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1511874, encodeId=d60815118e492, content=<a href='/topic/show?id=d88b891e376' target=_blank style='color:#2F92EE;'>#血流感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89173, encryptionId=d88b891e376, topicName=血流感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83b410387887, createdName=ms6829001416292975, createdTime=Thu May 16 01:20:00 CST 2019, time=2019-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=366210, encodeId=6b683662105f, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Tue May 14 10:48:30 CST 2019, time=2019-05-14, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1052890, encodeId=99b010528901f, content=请问出处在哪?, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76735610860, createdName=ms1000001709809472, createdTime=Sat Sep 18 21:28:53 CST 2021, time=2021-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796991, encodeId=7d971e969912b, content=<a href='/topic/show?id=5a6e221853a' target=_blank style='color:#2F92EE;'>#中心静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22185, encryptionId=5a6e221853a, topicName=中心静脉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8f4110, createdName=guojianrong, createdTime=Mon May 20 21:20:00 CST 2019, time=2019-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1697902, encodeId=a241169e9029c, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Wed Oct 30 19:20:00 CST 2019, time=2019-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1365550, encodeId=54d5136555082, content=<a href='/topic/show?id=e2ff2218823' target=_blank style='color:#2F92EE;'>#中心静脉导管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22188, encryptionId=e2ff2218823, topicName=中心静脉导管)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f32220, createdName=lancelotzzl, createdTime=Thu May 16 01:20:00 CST 2019, time=2019-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1511874, encodeId=d60815118e492, content=<a href='/topic/show?id=d88b891e376' target=_blank style='color:#2F92EE;'>#血流感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89173, encryptionId=d88b891e376, topicName=血流感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83b410387887, createdName=ms6829001416292975, createdTime=Thu May 16 01:20:00 CST 2019, time=2019-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=366210, encodeId=6b683662105f, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Tue May 14 10:48:30 CST 2019, time=2019-05-14, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1052890, encodeId=99b010528901f, content=请问出处在哪?, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76735610860, createdName=ms1000001709809472, createdTime=Sat Sep 18 21:28:53 CST 2021, time=2021-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796991, encodeId=7d971e969912b, content=<a href='/topic/show?id=5a6e221853a' target=_blank style='color:#2F92EE;'>#中心静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22185, encryptionId=5a6e221853a, topicName=中心静脉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8f4110, createdName=guojianrong, createdTime=Mon May 20 21:20:00 CST 2019, time=2019-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1697902, encodeId=a241169e9029c, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Wed Oct 30 19:20:00 CST 2019, time=2019-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1365550, encodeId=54d5136555082, content=<a href='/topic/show?id=e2ff2218823' target=_blank style='color:#2F92EE;'>#中心静脉导管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22188, encryptionId=e2ff2218823, topicName=中心静脉导管)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f32220, createdName=lancelotzzl, createdTime=Thu May 16 01:20:00 CST 2019, time=2019-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1511874, encodeId=d60815118e492, content=<a href='/topic/show?id=d88b891e376' target=_blank style='color:#2F92EE;'>#血流感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89173, encryptionId=d88b891e376, topicName=血流感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83b410387887, createdName=ms6829001416292975, createdTime=Thu May 16 01:20:00 CST 2019, time=2019-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=366210, encodeId=6b683662105f, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Tue May 14 10:48:30 CST 2019, time=2019-05-14, status=1, ipAttribution=)]
    2019-05-14 龙胆草

    学习谢谢分享

    0

相关资讯

Diabetic Med:南亚妊娠期糖尿病女性预防2型糖尿病的生活方式干预计划[LIVING研究]:随机试验方案

近日,国际杂志 《Diabetic Med》上在线发表一项关于南亚妊娠期糖尿病女性预防2型糖尿病的生活方式干预计划[LIVING研究]:随机试验方案的研究。

JAMA Intern Med:阿司匹林或可防肝癌!分析中国人群15年的数据发现,长期服用阿司匹林与慢性乙肝患者肝癌风险降低29%相关

今年3月份,和指南差不多时间,中国学者的研究成果迅速地巩固了阿司匹林的“神药”地位。台北容民总医院的Wu Chunying博士和其研究团队在《JAMA·内科医学》上发表文章,他们发现,服用阿司匹林与慢性乙型肝炎患者的肝癌发生风险降低29%有关。

Diabetes Obes Metab:对于服用非甾体类抗炎药的2型糖尿病患者,阿司匹林对继发性心血管疾病预防无益处

由此可见,在患有心血管疾病的2型糖尿病患者中,服用阿司匹林比服用NSAID的患者并非具有优势。

420高尿酸日:痛风如何预防 常用治疗痛风的药物有哪些副作用?

4月20日,是我们国家确定的高尿酸日,这源自高尿酸血症的诊断标准>420μmol/L。痛风的根本原因是高尿酸血症,在某些因素的诱导下,血尿酸在关节沉积刺激关节形成无菌性炎症导致痛风。预防痛风发作,首先要控制高尿酸血症。

Lancet Haematol:Emicizumab用于A型血友病出血预防

每4周一次Emicizumab对A型血友病患者出血具有良好的预防效果

Stroke:抗癫痫药物预防自发性脑出血后癫痫发作

由此可见,在自发性脑出血的成年患者中使用抗癫痫药物作为一级预防与长期随访期间改善的神经功能无关。未来的研究应侧重于在癫痫发作和预后不良的高风险患者中预防性使用不同的抗癫痫药物。